Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience
Posted On Monday, February 10, 2025
Ashvattha Presents Positive Phase 2 Data for Subcutaneous Migaldendranib at Angiogenesis 2025 Conference
Posted On Monday, February 10, 2025
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Posted On Monday, February 10, 2025
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Posted On Monday, February 10, 2025
Qu Biologics’ Immunomodulator Clears Senescence
Posted On Monday, February 10, 2025
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Posted On Monday, February 10, 2025
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
Posted On Friday, February 07, 2025
Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
Posted On Thursday, February 06, 2025
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
Posted On Thursday, February 06, 2025
North Texas Took Center Stage at Advanced Therapies Week 2025, Highlighting Innovation and Collaboration in Life Sciences
Posted On Thursday, February 06, 2025
Rakovina Therapeutics Announces Additional Synthesized Compounds in its AI-Driven Cancer Drug Discovery Program
Posted On Thursday, February 06, 2025
Fluorescent Tracers Market to Reach US$ 6.15 Billion by 2035, Expanding at 7.2% CAGR | Fact.MR Report
Posted On Thursday, February 06, 2025
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
Posted On Thursday, February 06, 2025
Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Posted On Wednesday, February 05, 2025
e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025
Posted On Wednesday, February 05, 2025
Medicenna Therapeutics to Participate in Two Healthcare Investor Conferences in February 2025
Posted On Wednesday, February 05, 2025
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
Posted On Tuesday, February 04, 2025
[Latest] Global Pharmacovigilance and Drug Safety Software Market Size/Share Worth USD 398.96 Million by 2033 at a 6.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate)
Posted On Monday, February 03, 2025
Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Posted On Monday, February 03, 2025
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference
Posted On Monday, February 03, 2025
George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs
Posted On Monday, February 03, 2025
Ocugen Announces Positive Opinion of European Medicines Agency’s Committee for Advanced Therapies for Advanced Therapy Medicinal Product Classification for Modifier Gene Therapy Candidate OCU400 for Retinitis Pigmentosa
Posted On Monday, February 03, 2025
SDC Partners with Singular to Advance Secure AI Solutions in Healthcare
Posted On Friday, January 31, 2025
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
Posted On Friday, January 31, 2025
SAB BIO to Participate in Upcoming Investor Conferences
Posted On Friday, January 31, 2025

First page
Previous page
…
83
84
85
86
87
88
89
90
91

Print